Fig. 1From: The cost-effectiveness of celecoxib versus non-steroidal anti-inflammatory drugs plus proton-pump inhibitors in the treatment of osteoarthritis in Saudi ArabiaSimplified version of the cost-effectiveness model structure. OA, osteoarthritisBack to article page